I'VE TAKEN IT TO THE VAXX
Daily Star|January 17, 2022
AN ex-squaddie reckons he is almost invincible to coronavirus after having had five vaccines.

Grandfather-of-five Daniel Sencier, 70, had been working in Thailand at the time of the outbreak and received two doses of Sinovac last year.

Continue reading your story on the app

Continue reading your story in the newspaper

RELATED STORIES

Waiting on mRNA Shots

Beijing refuses to allow Western vaccines even as the development of Chinese ones lags

4 mins read
Bloomberg Businessweek
May 02, 2022

Blocked

Luke came out as trans when he was 11, hoping to start hormone therapy as a teenager. Instead, he was held hostage in a political and medical battle that’s far from over.

10+ mins read
New York magazine
March 28-April 10, 2022

THAILAND BANS CRYPTOCURRENCY PAYMENTS FOR GOODS AND SERVICES

Thailand’s securities regulator announced Wednesday that it is barring the use of cryptocurrencies for payment of goods and services.

1 min read
Techlife News
March 26, 2022

Sojourn by the Sea

Discover plenty to smile about in Thailand’s exotic islands.

4 mins read
Global Traveler
March 2022

MOST EFFECTIVE COVID VACCINES

CDC says mRNA works – China’s jabs are JUNK!

1 min read
Globe
February 21, 2022

KANYA SESSER

New York Fashion Week is world-renowned for its spectacles. The entire industry turns its eager attention to each show, anticipating the opportunity to behold something never before seen. It’s a high standard to meet, and many shows fall short, but heads turned when Kanya Sesser hit the runway on her skateboard.

3 mins read
Inked
2021 Holiday Issue

HOPE

As countries slowly start to open up their borders, travel is beginning to bounce back.

5 mins read
Lens Magazine
November 2021

Change of Pace

Slow down and unwind in easy-going Phuket.

6 mins read
Global Traveler
September 2021

STAMP

Two Out of Three Ain’t Bad — For Most People. For STAMP FAIRTEX, However, It’s Not Enough!

9 mins read
Black Belt
April/May 2021

Can a Covid Vaccine Be Too Perfect?

The lack of serious side effects in China’s big trials is raising concerns about transparency

4 mins read
Bloomberg Businessweek
November 09, 2020